Ribonucleotide reductase

Assets acting on this target.

Class
Ribonucleotide reductase inhibitor (antimetabolite)

By indication

Related mechanisms

Ribonucleotide reductase drugs compared

3 drugs, stage by indication
3 drugs acting on Ribonucleotide reductase: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Hydroxyurea (Droxia)Cheplapharm Arzneimittel GmbH, Waylis Therapeutics LLCsmall moleculeApprovedApproved in Sickle Cell Disease
Hydroxyurea (Siklos)SiklosMedunik USA, Theraviasmall moleculeApprovedApproved in Sickle Cell Disease
Hydroxyurea (Xromi)XromiNova Laboratories Limited, Rare Disease Therapeuticssmall moleculeApprovedApproved in Sickle Cell Disease

← all mechanisms